Summary
This company is focused on developing innovative cell therapies aimed at treating various forms of cancer. They specialize in creating invariant T cells as a new standard in cancer treatment, emphasizing the development of universal allogeneic cell therapies. The team consists of experts in biology, immunology, and cell therapy, working towards programmable living therapeutics.